Scholars Central

Conference abstractPublished 15 Apr 2014

Diagnosing impaired glucose tolerance using direct mass spectrometry of blood plasma metabolites

Authors: Petr G. Lokhov, Oxana P. Trifonova, Dmitry L. Maslov, Elena B. Balashova, Maria V. Shestakova, Ekaterina A. Shestakova, Ivan I. Dedov, Alexander I. Archakov

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

C urrently, the glucose tolerance test (GTT) is the primary test and ?gold standard? for a diagnosis of impaired glucose tolerance (IGT). In addition, the GTT represents an important tool for identifying a prediabetic state and cardiovascular risk factors. However, this test has low reproducibility, is time consuming (takes 2 h), and some people may get sugar shock during test. Therefore, a more rapid and reproducible test for diagnosing IGT is needed. In recent decades, advances in high-throughput technologies have enabled large numbers of molecules to be analyzed in biosamples. For example, metabolomics involves the detection of metabolites, and in the case of bodily fluids, this capacity offers great potential for the diagnosis of metabolic disorders, including IGT. In our study, a metabolomics-based approach for a laboratory diagnosis of IGT is investigated. To this end, blood plasma samples from control subjects (n = 30) and patients with IGT (n = 20) were treated with methanol. The remaining low molecular weight metabolites present were then analyzed by direct infusion mass spectrometry. A total of 230 metabolite ions associated with IGT were detected. The area under a receiver operating characteristic (ROC) curve (AUC) for metabolite-based diagnostics of IGT was 0.94 (accuracy 92%, specificity 94%, and sensitivity 89%). The associated reproducibility was 85%. The metabolites identified were also consistent with risk factors previously associated with the development of diabetes. Thus, direct mass spectrometry of blood plasma metabolites represents a rapid, single-step, and reproducible method for the analysis of metabolites. Moreover, this method has the potential to serve as a prototype for clinical analyses that could replace the currently used glucose tolerance test with a more patient-friendly assay.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Biomarkers & Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Biomarkers & Diagnosis
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Petr G. Lokhov”
  • BylineArticles whose byline prints “Oxana P. Trifonova”
  • BylineArticles whose byline prints “Dmitry L. Maslov”
  • BylineArticles whose byline prints “Elena B. Balashova”
  • BylineArticles whose byline prints “Maria V. Shestakova”
  • BylineArticles whose byline prints “Ekaterina A. Shestakova”
  • BylineArticles whose byline prints “Ivan I. Dedov”
  • BylineArticles whose byline prints “Alexander I. Archakov”